Back

Is it justified to remove the intermediate risk group in the latest European guidelines for NSTEACS?

27 August 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Acute Coronary Syndromes ePosters Epidemiology, Prognosis, Outcome ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Mrs Teba Gonzalez Ferrero

La Paz University Hospital, Madrid (Spain)

205 More presentations in this session

Presentation thumbnail
Optimal timing of intervention in NSTE-ACS without pre-treatment
Doctor I. Almeida (Lisbon, PT)
Abstract Slides
Presentation thumbnail
Antithrombotic strategy in patients with atrial fibrillation and acute coronary syndrome
Doctor I. Almeida (Lisbon, PT)
Abstract Slides
Presentation thumbnail
Drug-eluting balloon catheters in the treatment of left main coronary artery bifurcation lesions: 4-years follow-up
Associate Professor D. Maximkin (Moscow, RU)
Abstract Slides
Presentation thumbnail
Clinical outcomes by angiographic type of spontaneous coronary artery dissection
Doctor R. Mori Junco (Madrid, ES)
Abstract Slides
Presentation thumbnail
Clinical impact of CREDO-kyoto risk score on in-hospital bleeding in patients with acute coronary syndrome
Doctor Y. Minematsu (Saga, JP)
Abstract Slides

Access the full session

Session thumbnail
Acute Coronary Syndromes ePosters

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources